Additionally, ETV1‐positive PCa samples from TCGA‐PRAD showed a statistically significant increase in both EGFR and STAT3 expression when comparing with ETS‐negative PCa, while STAT5A was not associated with the ETS profile. This evidence concerns the gene STAT5A and prostate adenocarcinoma.